Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RITURNS II: Repeated Rituximab vs MMF in SDNS
NCT03899103Phase 3Completed
- Sponsor
- Nil Ratan Sircar Medical College and Hospital
- Start
- May 2019
- Primary completion
- Sep 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in nephrotic syndrome, sponsored by Nil Ratan Sircar Medical College and Hospital. Started May 2019; status: completed.
02
Drugs
rituximab
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT03899103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03899103.